IRADIMED CORP — Director's Dealing 2025

Jun 24, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2025-06-20

Reporting Person: GLENN JOHN (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-20	Common Stock	M	5796	—	Acquired	14563	Direct
2025-06-20	Common Stock	F	1412	$58.24	Disposed	13151	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-06-20	Restricted Stock Units	$	M	5796	Disposed		Common Stock (5796)	Direct

Footnotes

F1: Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis.

F2: On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested.